Cytosorbents Crp (CTSO) earnings · rev $37.1M
These earnings events as JSON? API free 100/dayCytosorbents Crp (CTSO) is a medical devices company listed on US.
This CTSO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CTSO revenue for 2025-12-31 was $37.1M. Net income was -$8.2M. Revenue was up 4.1% from 2024-12-31 to 2025-12-31. CTSO currently screens at market cap $28.8M.
When the next CTSO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 4.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CTSO research stays on the stock page; the tape stays on the quote page.
CTSO earnings FAQ
What are CTSO's latest revenue and net income?
Latest cached Cytosorbents Crp (CTSO) revenue for Dec 31, 2025 was $37.1M. Net income was -$8.2M. Statements: https://lician.com/financials/ctso
What is CTSO's latest diluted EPS?
Latest cached Cytosorbents Crp (CTSO) diluted EPS for Dec 31, 2025 was -$0.13.
What period does the latest CTSO earnings print cover?
The latest cached Cytosorbents Crp (CTSO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did CTSO revenue change from the prior cached period?
Cached Cytosorbents Crp (CTSO) revenue was up 4.1% from $35.6M (Dec 31, 2024) to $37.1M (Dec 31, 2025). Statements: https://lician.com/financials/ctso
Where are CTSO earnings listed?
Cached earnings facts for Cytosorbents Crp (CTSO) are listed at https://lician.com/earnings/ctso. Statements: https://lician.com/financials/ctso
Not investment advice.